GPX4 and polycystic ovary syndrome: Previous studies have demonstrated that metformin can increase the expression of SIRT3 and GPX4, significantly elevate the levels of p-mTOR and p-AMPK, and improve polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis (68).